EarningsQ2 2026 Earnings Report

Supernus Pharmaceuticals (S49) Q2 2026 Earnings Report

0 Followers

DE:S49 Q2 2026 EPS Results

Actual EPS€0.47

Consensus EPS€0.38

Beat/MissBeat by +€0.09

One Year Ago EPS€0.81

Actual Revenue€195.45M

Expected Revenue€183.18M

Beat/MissBeat by +€12.26M

YoY Revenue Growth+32.40%

QuarterQ2 2026

Date08/03/2026

TimeBefore Open

Conference CallMonday, August 3, 2026

DE:S49 Upcoming Earnings

Supernus Pharmaceuticals's next earnings date is estimated for November 10, 2026, based on past reporting schedules.

DE:S49 Q2 2026 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 10, 2026	2026 (Q3)	0.55 / -	0.897	―
Aug 03, 2026	2026 (Q2)	0.38 / 0.47	0.81	-42.07% (-0.34)
May 05, 2026	2026 (Q1)	0.27 / 0.54	0.391	37.44% (+0.15)
Feb 24, 2026	2025 (Q4)	0.30 / 0.75	0.666	13.40% (+0.09)
Nov 04, 2025	2025 (Q3)	0.53 / 0.90	1.042	-13.96% (-0.15)
Aug 05, 2025	2025 (Q2)	0.42 / 0.81	0.688	17.77% (+0.12)
May 06, 2025	2025 (Q1)	0.33 / 0.39	0.41	-4.78% (-0.02)
Feb 25, 2025	2024 (Q4)	0.46 / 0.67	0.788	-15.52% (-0.12)
Nov 04, 2024	2024 (Q3)	0.40 / 1.04	-0.259	502.76% (+1.30)
Aug 06, 2024	2024 (Q2)	0.35 / 0.69	-0.018	3955.00% (+0.71)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed